Lotemax Co 5 mg Eye drops, suspension

    Lotemax Co 5 mg Eye drops, suspension

    S4
    PDF Leaflet Revision Date: 10 August 2022

    API: Loteprednol Etabonate | Company: Soflens

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of bacterial ocular infections and inflammatory conditions.

    Dosage (summary)

    1-2 drops every 4-6 hours; may increase to 1-2 hours initially.

    Special Populations

    • Elderly
    • Paediatric population

    Pregnancy & Breastfeeding

    Not established; contraindicated in pregnancy and breastfeeding.

    Key Drug Interactions

    • CYP3A inhibitors
    • Neuromuscular blocking agents

    Contraindications

    • Hypersensitivity to components
    • Viral infections of the eye

    Common side effects

    • Burning/stinging
    • Increased intraocular pressure
    • Headache

    Counselling Points

    • Do not touch the applicator tip
    • Avoid contact lenses during use
    • Monitor for increased intraocular pressure

    Serious warnings

    • Prolonged use may cause glaucoma
    • Risk of secondary infections
    Important Disclaimer

    The Lotemax Co 5 mg Eye drops, suspension professional information leaflet below is the property of Soflens and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn